Details for New Drug Application (NDA): 089594
✉ Email this page to a colleague
NDA 089594 describes CARISOPRODOL AND ASPIRIN, which is a drug marketed by Chartwell Rx, Genus, Novast Labs, and Oxford Pharms, and is included in four NDAs. Additional details are available on the CARISOPRODOL AND ASPIRIN profile page.
The generic ingredient in CARISOPRODOL AND ASPIRIN is aspirin; carisoprodol. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; carisoprodol profile page.
The generic ingredient in CARISOPRODOL AND ASPIRIN is aspirin; carisoprodol. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; carisoprodol profile page.
Summary for 089594
| Tradename: | CARISOPRODOL AND ASPIRIN |
| Applicant: | Chartwell Rx |
| Ingredient: | aspirin; carisoprodol |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 325MG;200MG | ||||
| Approval Date: | Mar 31, 1989 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
